Scopio Labs, a healthtech startup based in Tel Aviv, Israel, has raised $7 million in funding to expand its development. OurCrowd, an equity crowdfunding platform, contributed $2.5 million. The other backers have not been disclosed.
The company creates digital microscopes based on computational imaging, in addition to dedicated image analysis tools for various medical fields. It is currently developing a diagnostics platform based on advanced digital microscopy.
Scopio Labs will use these funds to expand its team with computer vision experts, physicists, and software developers, according to a statement from OurCrowd. Its tools enable clinical and research improvements in cancer, hematology, and cytology, as well as innovation in academic research and drug discovery.
“We are excited by our latest investment in Scopio Labs, which is bringing about a revolution in digital microscopy. Scopio Labs joins our portfolio of 23 cutting edge disruptive healthcare technology companies, all of which impact positively the lives of millions of people and are transforming patient care,” said OurCrowd CEO Jon Medved in a statement quoted by Globes.
Read more: FinSMEs